Heptabarbital
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.[2][3] It was previously used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.[2][3]
References
References
- ↑ 1.0 1.1 1.2 1.3 Breimer DD, de Boer AG (December 1975). “Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man”. European Journal of Clinical Pharmacology. 9 (2–3): 169–78. doi:10.1007/bf00614014. PMID 9299.
- ↑ 2.0 2.1 C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1003. ISBN 978-0-412-46630-4. Retrieved 26 November 2011.
- ↑ 3.0 3.1 Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 513. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
